The Saudi Food and Drug Authority (SFDA) has signed a Memorandum of Understanding (MoU) with the Association for the Advancement of Medical Instrumentation (AAMI) to enhance collaboration in the medical devices sector.
The partnership will focus on advancing technologies such as artificial intelligence and biotechnology to support innovation in medical diagnosis and treatment.
A delegation from Advancement of Medical Instrumentation, led by Chairman of the Board of Directors Walt Rosebrough, visited the SFDA headquarters in Riyadh. They reviewed the SFDA’s work and efforts in the medical devices sector and met with several officials.
The MoU outlines several areas of cooperation, including the development of medical device standards and related activities, the exchange of technical and scientific information, and the provision of expert consultations. The two sides will also coordinate on educational programs, joint events, and participation in international technical committees.
This partnership aligns with the SFDA’s commitment to collaborating with international organizations to develop policies and build technical capabilities, supporting the goals of the Health Sector Transformation Program, a key initiative of Saudi Vision 2030.
AAMI
The Association for the Advancement of Medical Instrumentation is a non-profit organization based in the United States, dedicated to the development, management, and safe use of medical technology. Founded in 1967, AAMI serves as a leading global authority in health technology standards, education, certification, and innovation.
AAMI is a recognized global leader in developing national and international consensus standards for medical devices and is a trusted source of scientific expertise and training. By applying global best practices, AAMI plays a key role in advancing the medical device industry.
